PIM1, a novel target in chemotherapy-resistant triple-negative breast cancer

被引：0
|
作者：
Braso-Maristany, Fara
Filosto, Simone
Catchpole, Steven
Marlow, Rebecca
Quist, Jelmar
Domenech, Erika Francesch
Liccardi, Gianmaria
Zakka, Leila
Serra, Violeta
Gris, Albert
Cheang, Maggie
Patel, Nirmesh
Rosell, Anna Perdrix
Gazinska, Patrycja
Noel, Elodie
Watkins, Jonathan
Marra, Pierfrancesco
Grigoriadis, Anita
Tutt, Andrew
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-178
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
178
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Chemotherapy-Resistant Metastatic Breast Cancer
    Marquette, Carrie
    Nabell, Lisle
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (02) : 263 - 275
  • [42] BRAF: An emerging target for triple-negative breast cancer
    Albanell, Joan
    Elvin, Julia Andrea
    Ali, Siraj Mahamed
    Schrock, Alexa Betzig
    Chung, Jon
    Vergilio, Jo-Anne
    Suh, James
    Ramkissoon, Shakti
    Severson, Eric Allan
    Daniel, Sugganth
    Miller, Vincent A.
    Stephens, Philip J.
    Gay, Laurie M.
    Ross, Jeffrey S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [43] (+)-Dehydroabietylamine derivatives target triple-negative breast cancer
    Ling, Taotao
    Tran, My
    Gonzalez, Miguel A.
    Gautam, Lekh Nath
    Connelly, Michele
    Wood, Rachael K.
    Fatima, Iram
    Miranda-Carboni, Gustavo
    Rivas, Fatima
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 102 : 9 - 13
  • [44] CDC20 is a novel therapeutic target in triple-negative breast cancer
    Sharma, Jayesh K.
    Alluri, Prasanna
    Udden, Nashir
    CANCER RESEARCH, 2020, 80 (16)
  • [45] CD74: a potential novel target for triple-negative breast cancer
    Tian, Buxian
    Zhang, Yuhong
    Li, Nan
    Liu, Xuewen
    Dong, Jianfeng
    TUMOR BIOLOGY, 2012, 33 (06) : 2273 - 2277
  • [46] Management of chemotherapy-resistant breast cancer
    Miles, DW
    Rubens, RD
    BREAST, 1996, 5 (04): : 288 - 292
  • [47] PIM1 kinase as a target for cancer therapy
    Merkel, Anna Lena
    Meggers, Eric
    Ocker, Matthias
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (04) : 425 - 436
  • [48] Genome-wide copy number analysis of chemotherapy-resistant metastatic triple-negative breast cancer from cell-free DNA
    Stover, Daniel G.
    Parsons, Heather A.
    Ha, Gavin
    Freeman, Sam
    Barry, Bill
    Guo, Hao
    Choudhury, Atish
    Gydush, Greg
    Reed, Sarah
    Rhoades, Justin
    Rotem, Denisse
    Hughes, Melissa E.
    Dillon, Deborah A.
    Partridge, Ann H.
    Wagle, Nikhil
    Krop, Ian E.
    Getz, Gad
    Golub, Todd A.
    Love, J. Christopher
    Winer, Eric P.
    Tolaney, Sara M.
    Lin, Nancy U.
    Adalsteinsson, Viktor A.
    CANCER RESEARCH, 2018, 78 (04)
  • [49] Chemotherapy-Resistant Metastatic Breast Cancer
    Carrie Marquette
    Lisle Nabell
    Current Treatment Options in Oncology, 2012, 13 : 263 - 275
  • [50] CLDN1 Sensitizes Triple-Negative Breast Cancer Cells to Chemotherapy
    Lemesle, Marine
    Geoffroy, Marine
    Alpy, Fabien
    Tomasetto, Catherine-Laure
    Kuntz, Sandra
    Grillier-Vuissoz, Isabelle
    CANCERS, 2022, 14 (20)
12345